mark2The Antiviral Drug Discovery and Development Center (AD3C), coordinated out of the University of Alabama at Birmingham (UAB) has, at its center, the theme to develop new small molecule therapeutics for emerging and re-emerging viral infections.

AD3C focuses on developing drugs for four virus families: influenza, flavi-, corona- and alphaviruses. It is funded by a U19 through the CETR program at NIAID.